share_log

MSCI Inc | 8-K: Current report

MSCI Inc | 8-K: Current report

MSCI Inc | 8-K：重大事件
美股SEC公告 ·  2024/08/01 18:51

Moomoo AI 已提取核心信息

MSCI announced the appointment of Michelle Seitz as an independent director to its Board of Directors, effective August 5, 2024. Seitz will serve on the Board's Audit and Risk Committee, bringing the total board membership to 12 directors. As per the non-employee director compensation program, she will receive an annual retainer of $90,000 and restricted stock units worth $210,000, plus an additional $10,000 for committee service.Seitz brings extensive investment industry experience as the current Founder and CEO of MeydenVest Partners and former Chair and CEO of Russell Investments (2017-2022). Her prior experience includes leadership roles at William Blair, where she served as CEO of William Blair Investment Management and drove fivefold growth. She currently serves on the board of Sana Biotechnology and holds a CFA designation.The appointment follows an extensive search initiated last year, with MSCI Chairman and CEO Henry Fernandez highlighting Seitz's three decades of asset management experience and track record in driving transformational growth. The Board has confirmed her independence under both NYSE and SEC standards.
MSCI announced the appointment of Michelle Seitz as an independent director to its Board of Directors, effective August 5, 2024. Seitz will serve on the Board's Audit and Risk Committee, bringing the total board membership to 12 directors. As per the non-employee director compensation program, she will receive an annual retainer of $90,000 and restricted stock units worth $210,000, plus an additional $10,000 for committee service.Seitz brings extensive investment industry experience as the current Founder and CEO of MeydenVest Partners and former Chair and CEO of Russell Investments (2017-2022). Her prior experience includes leadership roles at William Blair, where she served as CEO of William Blair Investment Management and drove fivefold growth. She currently serves on the board of Sana Biotechnology and holds a CFA designation.The appointment follows an extensive search initiated last year, with MSCI Chairman and CEO Henry Fernandez highlighting Seitz's three decades of asset management experience and track record in driving transformational growth. The Board has confirmed her independence under both NYSE and SEC standards.
MSCI宣布任命Michelle Seitz为其董事会的独立董事，任职自2024年8月5日起生效。Seitz将担任董事会的审计和风险委员会成员，使董事会的总人数达到12位董事。根据非员工董事薪酬计划，她将获得每年90,000美元的固定薪酬和价值210,000美元的限制性股票单位，以及为委员会服务额外的10,000美元。Seitz在投资行业拥有丰富的经验，她是MeydenVest Partners的创始人兼首席执行官，曾担任Russell Investments的董事长兼首席执行官（2017-2022）。她的之前经历包括在William Blair担任CEO，推动了William Blair投资...展开全部
MSCI宣布任命Michelle Seitz为其董事会的独立董事，任职自2024年8月5日起生效。Seitz将担任董事会的审计和风险委员会成员，使董事会的总人数达到12位董事。根据非员工董事薪酬计划，她将获得每年90,000美元的固定薪酬和价值210,000美元的限制性股票单位，以及为委员会服务额外的10,000美元。Seitz在投资行业拥有丰富的经验，她是MeydenVest Partners的创始人兼首席执行官，曾担任Russell Investments的董事长兼首席执行官（2017-2022）。她的之前经历包括在William Blair担任CEO，推动了William Blair投资管理业务的五倍增长。她目前在Sana生物技术公司担任董事，并持有CFA资格。该任命是在去年启动的广泛搜索之后作出的，MSCI主席兼首席执行官Henry Fernandez强调了Seitz在资产管理领域三十年的经验以及推动转型增长的卓越记录。董事会已经确认她在纽交所和SEC标准下的独立性。

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    MarketWise
    MKTW
    -- 0.650
    Bit Origin
    BTOG
    -- 0.4504
    MSCI Inc
    MSCI
    -- 572.630
    Value Line
    VALU
    -- 34.360
    邓白氏
    DNB
    -- 10.640
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球市场会如何演变？
    🎙️讨论： 1. 关税政策将如何影响美股、黄金、比特币等核心资产的走势？ 2. 在此背景下，有哪些投资机会值得关注？你会如何布局？ 展开
    MicroStrategy 2024年第四季度业绩电话会
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。